TRCT
CVRX icon

Tower Research Capital (TRC)’s CVRx CVRX Stock Holding History

Tower Research Capital (TRC)’s Portfolio CVRX Stock Details CVRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.72K Buy
1,892
+686
+57% +$4.43K ﹤0.01% 4016
2026
Q1 		$11.4K Sell
1,206
-1,069
-47% -$7.82K ﹤0.01% 3847
2025
Q4 		$16.2K Buy
2,275
+546
+32% +$4.98K ﹤0.01% 3264
2025
Q3 		$14K Sell
1,729
-1,527
-47% -$11.5K ﹤0.01% 3638
2025
Q2 		$19.1K Buy
3,256
+2,096
+181% +$14.5K ﹤0.01% 3707
2025
Q1 		$14.2K Sell
1,160
-2,740
-70% -$38.7K ﹤0.01% 3310
2024
Q4 		$49.4K Buy
3,900
+1,186
+44% +$14.6K ﹤0.01% 2557
2024
Q3 		$23.9K Buy
2,714
+368
+16% +$3.35K ﹤0.01% 3140
2024
Q2 		$28.1K Buy
2,346
+856
+57% +$9.86K ﹤0.01% 3535
2024
Q1 		$27.1K Buy
1,490
+428
+40% +$10.1K ﹤0.01% 2733
2023
Q4 		$33.4K Sell
1,062
-2,030
-66% -$38.1K ﹤0.01% 3360
2023
Q3 		$46.9K Buy
3,092
+2,357
+321% +$38.8K ﹤0.01% 2598
2023
Q2 		$11.3K Sell
735
-2,241
-75% -$27.3K ﹤0.01% 3986
2023
Q1 		$28K Buy
+2,976
New +$39.4K ﹤0.01% 3063
2022
Q4 		– Sell
-9,382
Closed -$88K – 5953
2022
Q3 		$88K Buy
+9,382
New +$74.3K ﹤0.01% 2672
2022
Q2 		– Sell
-16,640
Closed -$100K – 6134
2022
Q1 		$100K Buy
16,640
+10,363
+165% +$83.7K ﹤0.01% 2193
2021
Q4 		$76K Buy
6,277
+5,631
+872% +$81.7K ﹤0.01% 2426
2021
Q3 		$11K Buy
+646
New +$12.4K ﹤0.01% 4214

Other funds holding CVRX

JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SAM
Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Tower Research Capital (TRC)'s CVRX Position: Q2 2026 in Review

Tower Research Capital (TRC) increased its CVRx (CVRX) stake by 57% in Q2 2026, buying an estimated $4.43K and bringing the position to 1,892 shares worth $9.72K. The position accounts for ﹤0.01% of the portfolio, ranked #4016.

Tower Research Capital (TRC) first reported a position in CVRX in Q3 2021 and has held it in 18 quarters since. The position peaked at $100K in Q1 2022. 88 funds tracked by Wall St. Rank hold CVRX as of Q2 2026.

  • Tower Research Capital (TRC) held 1,892 shares of CVRx worth $9.72K as of Q2 2026.
  • Tower Research Capital (TRC) bought 686 CVRx shares in Q2 2026, an estimated $4.43K.
  • CVRx made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #4016 holding.
  • Tower Research Capital (TRC) first reported a position in CVRx in Q3 2021 and has held it in 18 quarters since.
  • Tower Research Capital (TRC)'s CVRx position peaked at $100K in Q1 2022.
  • 88 funds tracked by Wall St. Rank held CVRx as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.